Drp1 activates ROS/HIF-1α/EZH2 and triggers mitochondrial fragmentation to deteriorate hypercalcemia-associated neuronal injury in mouse model of chronic kidney disease

J Neuroinflammation. 2022 Sep 1;19(1):213. doi: 10.1186/s12974-022-02542-7.

Abstract

Background: Chronic kidney disease (CKD), characterized as renal dysfunction, is regarded as a major public health problem which carries a high risk of cardiovascular diseases. The purpose of this study is to evaluate the functional significance of Drp1 in hypercalcemia-associated neuronal damage following CKD and the associated mechanism.

Methods: Initially, the CKD mouse models were established. Next, RT-qPCR and Western blot analysis were performed to measure expression of Fis1 and Drp1 in CKD. Chromatin immunoprecipitation (ChIP) assay and dual-luciferase reporter gene assay were utilized to explore the relationship among Drp1, HIF-1α, EZH2, and ROS with primary cortical neurons isolated from neonatal mice. Next, CKD mice were subjected to calcitonin treatment or manipulation with adenovirus expressing sh-Drp1, so as to explore the effects of Drp1 on hypercalcemia-induced neuronal injury in CKD. TUNEL assay and immunofluorescence staining were performed to detect apoptosis and NeuN-positive cells (neurons) in prefrontal cortical tissues of CKD mice.

Results: It was found that hypercalcemia could induce neuronal injury in CKD mice. An increase of Fis1 and Drp1 expression in cerebral cortex of CKD mice correlated with mitochondrial fragmentation. Calcitonin suppressed Drp1/Fis1-mediated mitochondrial fragmentation to attenuate hypercalcemia-induced neuronal injury after CKD. Additionally, Drp1 could increase EZH2 expression through the binding of HIF-1α to EZH2 promoter via elevating ROS generation. Furthermore, Drp1 knockdown inhibited hypercalcemia-induced neuronal injury in CKD while overexpression of EZH2 could reverse this effect in vivo.

Conclusion: Taken together, the key findings of the current study demonstrate the promotive role of Drp1 in mitochondrial fragmentation which contributes to hypercalcemia-induced neuronal injury in CKD.

Keywords: Chronic kidney disease; Drp1; EZH2; HIF-1α; Hypercalcemia; Mitochondrial fragmentation; Neuronal damage; ROS production.

MeSH terms

  • Animals
  • Apoptosis
  • Calcitonin / metabolism
  • Calcitonin / pharmacology
  • Disease Models, Animal
  • Dynamins / genetics
  • Dynamins / metabolism*
  • Enhancer of Zeste Homolog 2 Protein / metabolism
  • Hypercalcemia* / metabolism
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Mice
  • Mitochondria* / metabolism
  • Neurons / metabolism
  • Reactive Oxygen Species / metabolism
  • Renal Insufficiency, Chronic* / metabolism

Substances

  • Hif1a protein, mouse
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Reactive Oxygen Species
  • Calcitonin
  • Enhancer of Zeste Homolog 2 Protein
  • Ezh2 protein, mouse
  • Dnm1l protein, mouse
  • Dynamins